Journal article

Predictors of retention in a randomised trial of smoking cessation in low-socioeconomic status Australian smokers

Ryan J Courtney, Philip Clare, Veronica Boland, Kristy A Martire, Billie Bonevski, Wayne Hall, Mohammad Siahpush, Ron Borland, Christopher M Doran, Robert West, Michael Farrell, Richard P Mattick

Addictive Behaviors | PERGAMON-ELSEVIER SCIENCE LTD | Published : 2017


BACKGROUND AND AIMS: Little is known about the factors associated with retention in smoking cessation trials, especially for low-socioeconomic status (low-SES) smokers. This study examined the factors associated with retention of low-SES smokers in the Australian Financial Interventions for Smoking Cessation Among Low-Income Smokers (FISCALS) trial. DESIGN: A two-group parallel block randomised open-label trial with allocation concealment. SETTING: Australia. The study was conducted primarily by telephone-based interviews with nicotine replacement therapy delivered via mail. PARTICIPANTS: 1047 low-SES smokers interested in quitting smoking were randomised. MEASUREMENTS: Participants complete..

View full abstract


Awarded by Australian National Health and Medical Research Council (NHMRC)

Awarded by Cancer Institute New South Wales Early Career Research Fellowship

Awarded by NHMRC Career Development Fellowship

Awarded by NHMRC Principal Research Fellowship

Awarded by Cancer Research UK

Awarded by Economic and Social Research Council

Awarded by Medical Research Council

Funding Acknowledgements

We would like to thank Emma Black, Veronica Boland, Deborah Bradford, Danya Braunstein, Philip Clare, Jaimi Iredale, Sundresan Naicker, Joel Tibbetts, Lauren Touyz and Emily Upton for their work on the project. We acknowledge the assistance of Quitline services, and Australian Govemment Department of Human Services Centrelink Customer Service Centres, for assisting with recruitment and staff at the HRF for their diligence with data collection. This research is funded by a grant (APP1021862) from the Australian National Health and Medical Research Council (NHMRC). The National Drug and Alcohol Research Centre at the University of New South Wales (UNSW), Australia is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grants Fund and by infrastructure support from the UNSW, Australia. RJC is supported by a Cancer Institute New South Wales Early Career Research Fellowship (GNT14/ECF/1-46), BB is supported by a NHMRC Career Development Fellowship (GNT1063206) and RPM by a NHMRC Principal Research Fellowship (GNT1045318). GlaxoSmithKline provided NRT at a reduced cost for the study.